| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-18 |
| | 10-K | 10-K | 10-K | 10-K |
| Revenues | 45.2 | 30.1 | 19.2 | 11.7 |
| Revenue growth | 50.0% | 56.5% | | |
| Cost of goods sold | -33.1 | -9.7 | -0.3 | 0.0 |
| Gross profit | 78.3 | 39.8 | 19.5 | 11.7 |
| Gross margin | 173.2% | 132.1% | 101.5% | 100.0% |
| Selling, general and administrative [+] | 5.8 | 5.0 | 4.7 | 1.2 |
| General and administrative | 5.8 | 5.0 | 4.7 | 1.2 |
| Other operating expenses | 5.4 | 3.7 | 2.3 | 1.6 |
| EBITDA [+] | 67.1 | 31.1 | 12.6 | 8.9 |
| EBITDA growth | 115.6% | 147.7% | | |
| EBITDA margin | 148.3% | 103.2% | 65.2% | 76.1% |
| Depreciation | 14.8 | 10.0 | 6.2 | 3.4 |
| EBITA | 52.3 | 21.1 | 6.4 | 5.6 |
| EBITA margin | 115.7% | 70.2% | 33.1% | 47.4% |
| Amortization of intangibles | 8.8 | 6.0 | 3.8 | 1.5 |
| EBIT [+] | 43.5 | 15.2 | 2.6 | 4.0 |
| EBIT growth | 186.8% | 481.0% | | |
| EBIT margin | 96.2% | 50.3% | 13.6% | 34.3% |
| Interest expense, net [+] | -9.5 | -3.7 | -1.5 | |
| Interest expense | 9.5 | 3.7 | 1.5 | |
| Interest income | 9.5 | 3.7 | 1.5 | |
| Other income (expense), net [+] | -9.5 | -3.7 | -1.5 | |
| Gain (loss) on sale of assets | 33.8 | 9.7 | 0.3 | |
| Gain (loss) on debt retirement | -0.7 | | | |
| Pre-tax income | 34.0 | 11.5 | 1.1 | 4.0 |
| Income taxes | 4.2 | 1.5 | 0.2 | 0.0 |
| Tax rate | 12.5% | 13.1% | 14.0% | 0.0% |
| Minority interest | 4.2 | 1.5 | 0.2 | |
| Net income | 29.7 | 10.0 | 1.0 | 4.0 |
| Net margin | 65.7% | 33.1% | 5.1% | 34.3% |
| |
| Basic EPS [+] | $2.48 | $1.02 | $0.13 | |
| Growth | 143.6% | 684.8% | | |
| Diluted EPS [+] | $2.17 | $0.89 | $0.11 | |
| Growth | 145.2% | 692.6% | | |
| |
| Dividends per share [+] | $1.09 | $1.02 | $0.82 | |
| Growth | 7.4% | 23.8% | | |
| |
| Shares outstanding (basic) [+] | 12.0 | 9.8 | 7.6 | |
| Growth | 22.4% | 28.9% | | |
| Shares outstanding (diluted) [+] | 13.7 | 11.2 | 8.8 | |
| Growth | 21.6% | 27.6% | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |